Our Products

A tyrosine kinase inhibitor (TKI) used in the treatment of advanced kidney cancer (renal cell carcinoma) and liver cancer (hepatocellular carcinoma) in adults previously treated with the medicine sorafenib.

A tyrosine kinase inhibitor (TKI) used to treat people with medullary thyroid cancer (MTC) that has spread to other parts of the body (called metastatic MTC).

An analogue of the natural gonadotropin-releasing hormone (GnRH), approved for the treatment of locally advanced metastatic prostate cancer, central precocious puberty (CPP) endometriosis, uterine fibroma, and in-vitro fertilization, and used as adjuvant treatment in combination with tamoxifen or an aromatase inhibitor for women at high-risk of breast cancer recurrence.

An acetylcholine release inhibitor and a neuromuscular blocking agent indicated for:

Symptomatic treatment of focal spasticity of:

• Upper limbs in adults and pediatric patients
• Lower limbs in adults affecting the ankle joint due to stroke or traumatic brain injury (TBI)
• Dynamic equinus foot deformity in ambulant pediatric cerebral palsy patients, two years of age or older.

Also in adults for symptomatic treatment of:

• Spasmodic torticollis (cervical dystonia)
• Blepharospasm
• Hemifacial spasm
• Severe primary hyperhidrosis of the axillae, which does not respond to topical treatment with antiperspirants or antihidrotics.

Aesthetic treatment of:

• The temporary improvement in the appearance of moderate to severe glabellar lines associated with procerus and corrugator muscle activity in adults < 65 years of age.

A recombinant insulin-like growth factor (IGF-1) that treats growth delay in children with severe primary insulin-like growth factor deficiency (SPIGFD).

A liquid formulation of recombinant human growth hormone administered with the NutropinAq Pen. Used for the treatment of growth failure stemming from various origins.

Consists of a lipid bilayer vesicle, or liposome, that encapsulates irinotecan in an aqueous space and is indicated, in combination with fluorouracil (5-FU) and leucovorin (LV), for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy.

A synthetic (analogue) version of the natural hormone somatostatin, which is found naturally in the human body. Used for the treatment of neuroendocrine tumors (NETs), carcinoid syndrome or acromegaly.

A tryptophan hydroxylase inhibitor, an enzyme that mediates the rate-limiting stage of serotonin biosynthesis, which is used in the treatment of carcinoid syndrome diarrhea in patients whose symptoms are not adequately controlled with somatostatin analogue therapy (SSA).